Skip to main content
Log in

Modification of L-DOPA pharmacological activity by MAO inhibitors

  • Amine oxidases and disease
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Dopamine behaves mainly as a MAO-A substrate in rodent brain, but selective inhibition of MAO-B results in an increased turning activity following L-DOPA administration in hemi-Parkinsonian rodents. Unilateral substantia nigra dopaminergic denervation results in serotonergic hyper-innervation which may increase the contribution of MAO-A in the denervated striatum. Possibly as a result of this, there was no change in striatal MAO-A activity when 95% of dopaminergic innervation was reduced by 6-hydroxydopamine, as assessed by apomorphine-induced turning activity. MAO-B as well as MAO-A may contribute to deamination of dopamine produced from L-DOPA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AAADC:

aromatic amino-acid decarboxylase

COMT:

catechol-O-methyltransferase

DA:

dopamine

5,7-DHT:

5,7-dihydroxytryptamine

5-HT:

5-hydroxytryptamine

L-DOPA:

L-3,4-dihydroxyphenylalanine

LID:

L-DOPA-induced dyskinesias

MAO:

monoamine oxidase

6-OHDA:

6-hydroxydopamine

PD:

Parkinson’s disease

2-PEA:

2-phenylethylamine

snpc:

substantia nigra pars compacta

References

  • RL Albin AB Young JB Penney (1989) ArticleTitleThe functional anatomy of basal ganglia disorders Trends Neurosci 12 366–375 10.1016/0166-2236(89)90074-X Occurrence Handle10.1016/0166-2236(89)90074-X Occurrence Handle1:STN:280:DyaK3c%2FltVGjsA%3D%3D Occurrence Handle2479133

    Article  CAS  PubMed  Google Scholar 

  • R Arai N Karasawa K Kurokawa H Kanai K Horiike A Ito (2002) ArticleTitleDifferential subcellular location of mitochondria in rat serotonergic neurons depends on the presence and the absence of monoamine oxidase type B Neuroscience 114 825–835 Occurrence Handle1:CAS:528:DC%2BD38XnvVKjsrY%3D Occurrence Handle12379239

    CAS  PubMed  Google Scholar 

  • W Birkmayer P Riederer MB Youdim W Linnauer (1975) ArticleTitleThe potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil J Neural Transm 36 303–326 10.1007/BF01253131 Occurrence Handle10.1007/BF01253131 Occurrence Handle1:STN:280:DyaE28%2Fis1KitQ%3D%3D Occurrence Handle1172524

    Article  CAS  PubMed  Google Scholar 

  • T Brannan A Prikhojan J Martinez-Tica MD Yahr (1995) ArticleTitleIn vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism J Neural Transm P-D Sect 10 79–89 10.1007/BF02251224 Occurrence Handle10.1007/BF02251224 Occurrence Handle1:CAS:528:DyaK28Xhs1Krur4%3D

    Article  CAS  Google Scholar 

  • N Buu M Angers (1987) ArticleTitleEffects of different monoamine oxidase inhibitors on the metabolism of L-DOPA in the rat brain Biochem Pharmacol 36 1731–1735 10.1016/0006-2952(87)90060-8 Occurrence Handle10.1016/0006-2952(87)90060-8

    Article  Google Scholar 

  • IC Campbell DS Robinson W Lovenberg DL Murphy (1979) ArticleTitleThe effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain J Neurochem 32 49–55 10.1111/j.1471-4159.1979.tb04508.x Occurrence Handle10.1111/j.1471-4159.1979.tb04508.x Occurrence Handle1:CAS:528:DyaE1MXks1ynsbY%3D Occurrence Handle32233

    Article  CAS  PubMed  Google Scholar 

  • GC Cotzias MH Van Woert LM Schiffer (1967) ArticleTitleAromatic amino acids and modification of Parkinsonism N Engl J Med 276 374–379 Occurrence Handle1:CAS:528:DyaF2sXnsVymsQ%3D%3D Occurrence Handle5334614 Occurrence Handle10.1056/NEJM196702162760703

    Article  CAS  PubMed  Google Scholar 

  • L Dayan JPM Finberg (2003) ArticleTitleL-DOPA increases noradrenaline turnover in central and peripheral nervous systems Neuropharmacology 45 524–533 10.1016/S0028-3908(03)00190-4 Occurrence Handle10.1016/S0028-3908(03)00190-4 Occurrence Handle1:CAS:528:DC%2BD3sXlvFGhtr8%3D Occurrence Handle12907313

    Article  CAS  PubMed  Google Scholar 

  • KT Demarest DJ Smith AJ Azzaro (1980) ArticleTitleThe presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons J Pharmacol Exp Ther 215 461–468 Occurrence Handle1:CAS:528:DyaL3cXmtFyntbk%3D Occurrence Handle7441510

    CAS  PubMed  Google Scholar 

  • DA Di Monte LE DeLanney I Irwin JE Royland P Chan MW Jakowec JW Langston (1996) ArticleTitleMonoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys Brain Res 738 53–59 10.1016/0006-8993(96)00761-5 Occurrence Handle10.1016/0006-8993(96)00761-5 Occurrence Handle1:CAS:528:DyaK28Xms1aqu7g%3D Occurrence Handle8949927

    Article  CAS  PubMed  Google Scholar 

  • RC Duvoisin C Mytilineou (1972) ArticleTitleWhere is L-DOPA decarboxylated in the striatum after 6-hydroxydopamine nigrotomy? Brain Res 152 369–373 10.1016/0006-8993(78)90266-4 Occurrence Handle10.1016/0006-8993(78)90266-4

    Article  Google Scholar 

  • JPM Finberg MBH Youdim (2002) ArticleTitlePharmacological properties of the anti-Parkinson drug rasagiline: modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviors Neuropharmacology 43 1110–1118 10.1016/S0028-3908(02)00216-2 Occurrence Handle10.1016/S0028-3908(02)00216-2 Occurrence Handle1:CAS:528:DC%2BD38Xps12lsr8%3D Occurrence Handle12504917

    Article  CAS  PubMed  Google Scholar 

  • JPM Finberg J Wang DS Goldstein IJ Kopin KS Bankiewicz (1995) ArticleTitleInfluence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats J Neurochem 65 1213–1220 Occurrence Handle1:CAS:528:DyaK2MXns1eisro%3D Occurrence Handle7643100 Occurrence Handle10.1046/j.1471-4159.1995.65031213.x

    Article  CAS  PubMed  Google Scholar 

  • JPM Finberg J Wang K Bankiewicz J Harvey-White IJ Kopin DS Goldstein (1998) ArticleTitleIncreased striatal dopamine production from l-dopa following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey J Neural Transm Suppl 52 279–285

    Google Scholar 

  • F Hefti E Melamed RJ Wurtman (1981) ArticleTitleThe site of dopamine formation in rat striatum after L-Dopa administration J Pharmacol Exp Ther 217 189–197 Occurrence Handle1:CAS:528:DyaL3MXhtlaku74%3D Occurrence Handle7205652

    CAS  PubMed  Google Scholar 

  • T Ilani I Lamensdorf JPM Finberg (2000) ArticleTitleSelective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig Br J Phamacol 130 1992–1998 Occurrence Handle10.1038/sj.bjp.0703493 Occurrence Handle1:CAS:528:DC%2BD3cXmtFems7g%3D

    Article  CAS  Google Scholar 

  • K Jellinger (1991) ArticleTitlePathology of Parkinson’s disease. Changes other than the nigrostriatal pathway Mol Chem Neuopathol 14 153–197 Occurrence Handle10.1007/BF03159935 Occurrence Handle1:CAS:528:DyaK38XkvVOmt7g%3D

    Article  CAS  Google Scholar 

  • S Kaseda M Nomoto S-I Iwata (1999) ArticleTitleEffect of selegiline on dopamine concentration in the striatum of a primate Brain Res 815 44–50 10.1016/S0006-8993(98)01089-0 Occurrence Handle10.1016/S0006-8993(98)01089-0 Occurrence Handle1:CAS:528:DyaK1cXnvVSlsLw%3D Occurrence Handle9974121

    Article  CAS  PubMed  Google Scholar 

  • I Lamensdorf MBH Youdim JPM Finberg (1996) ArticleTitleThe effect of long term treatment with monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo J Neurochem 67 1532–1539 Occurrence Handle1:CAS:528:DyaK28XmtVWitLw%3D Occurrence Handle8858937 Occurrence Handle10.1046/j.1471-4159.1996.67041532.x

    Article  CAS  PubMed  Google Scholar 

  • P Langlier A Parent LJ Poirier (1972) ArticleTitleDecarboxylase activity of the brain capillary wall and parenchyma in the rat, cat and monkey Brain Res 45 622–629 10.1016/0006-8993(72)90495-7 Occurrence Handle10.1016/0006-8993(72)90495-7

    Article  Google Scholar 

  • P Levitt JE Pintar XO Breakefield (1982) ArticleTitleImmunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons Proc Nat Acad Sci 79 6385–6389 10.1073/pnas.79.20.6385 Occurrence Handle10.1073/pnas.79.20.6385 Occurrence Handle1:CAS:528:DyaL38XmtV2isb8%3D Occurrence Handle6755469

    Article  CAS  PubMed  Google Scholar 

  • T Maeda K Kannari H Shen A Arai M Tomiyama M Matsunaga T Suda (2003) ArticleTitleRapid induction of serotonergic hyperinnervation in the adult rat striatum with extensive dopaminergic denervation Neurosci Lett 343 17–20 10.1016/S0304-3940(03)00295-7 Occurrence Handle10.1016/S0304-3940(03)00295-7 Occurrence Handle1:CAS:528:DC%2BD3sXjs1Crsr4%3D Occurrence Handle12749987

    Article  CAS  PubMed  Google Scholar 

  • T Maeda K Nagata Y Toshida K Kannari (2005) ArticleTitleSerotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA Brain Res 1046 240–243 10.1016/j.brainres.2005.04.019 Occurrence Handle10.1016/j.brainres.2005.04.019 Occurrence Handle1:CAS:528:DC%2BD2MXltVOlt7w%3D

    Article  CAS  Google Scholar 

  • D Moses A Gross JPM Finberg (2004) ArticleTitleRasagiline enhances L-DOPA-induced contralateral turning in the unilateral 6-hydroxydopamine-lesioned guinea-pig Neuropharmacology 47 72–80 10.1016/j.neuropharm.2004.02.016 Occurrence Handle10.1016/j.neuropharm.2004.02.016 Occurrence Handle1:CAS:528:DC%2BD2cXksVagtb8%3D Occurrence Handle15165835

    Article  CAS  PubMed  Google Scholar 

  • A Mura D Jackson MS Manley SJ Young PM Groves (1995) ArticleTitleAromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine Brain Res 704 51–60 10.1016/0006-8993(95)01104-8 Occurrence Handle10.1016/0006-8993(95)01104-8 Occurrence Handle1:CAS:528:DyaK2MXhtVSgsL3I Occurrence Handle8750961

    Article  CAS  PubMed  Google Scholar 

  • KY Ng TN Chase RW Colburn IJ Kopin (1970) ArticleTitleL-dopa-induced release of cerebral catecholamines Science 170 76–77 10.1126/science.170.3953.76 Occurrence Handle10.1126/science.170.3953.76 Occurrence Handle1:CAS:528:DyaE3cXltFyrs7Y%3D Occurrence Handle5452893

    Article  CAS  PubMed  Google Scholar 

  • AM O’Carroll CJ Fowler JP Phillips I Tobbia KF Tipton (1983) ArticleTitleThe deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions N-S Arch Pharmacol 322 198–202 10.1007/BF00500765 Occurrence Handle10.1007/BF00500765

    Article  Google Scholar 

  • CW Olanow Y Agid Y Mizuno et al. (2004) ArticleTitleLevodopa in the treatment of Parkinson’s disease: current controversies Mov Disord 19 997–1005 10.1002/mds.20243 Occurrence Handle10.1002/mds.20243 Occurrence Handle15372588

    Article  PubMed  Google Scholar 

  • D Orosz JP Bennett (1992) ArticleTitleSimultaneous microdialysis in striatum and substantia nigra suggest that the nigra is a major site of action of L-dihydroxyphenylalanine in the “hemiparkinsonian” rat Exp Neurol 115 388–393 10.1016/0014-4886(92)90203-3 Occurrence Handle10.1016/0014-4886(92)90203-3 Occurrence Handle1:CAS:528:DyaK38Xhs1KitLk%3D Occurrence Handle1537396

    Article  CAS  PubMed  Google Scholar 

  • InstitutionalAuthorNameParkinson Study Group (2002) ArticleTitleA controlled trial of rasagiline in early Parkinson disease Arch Neurol 59 1937–1943 10.1001/archneur.59.12.1937 Occurrence Handle10.1001/archneur.59.12.1937

    Article  Google Scholar 

  • IA Paterson AV Juorio MD Berry MY Zhu (1991) ArticleTitleInhibition of monoamine oxidase B by (−-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum J Pharmacol Exp Ther 258 1019–1026 Occurrence Handle1:CAS:528:DyaK3MXlvFynt74%3D Occurrence Handle1679846

    CAS  PubMed  Google Scholar 

  • IA Paterson BA Davis DA Durden AV Juorio PH Yu G Ivy W Milgram A Mendonca P Wu AA Boulton (1995) ArticleTitleInhibition of MAO-B by (−-deprenyl alters dopamine metabolism in the macaque (Macaca fascicularis) brain Neurochem Res 20 1503–1510 10.1007/BF00970600 Occurrence Handle10.1007/BF00970600 Occurrence Handle1:CAS:528:DyaK28XjslCntQ%3D%3D Occurrence Handle8789614

    Article  CAS  PubMed  Google Scholar 

  • S Sarre D Vandeneede G Ebinger Y Michotte (1998) ArticleTitleBiotransformation of L-DOPA to dopamine in the substantia nigra of freely moving rats: effect of dopamine receptor agonists and antagonists J Neurochem 70 1730–1739 Occurrence Handle1:CAS:528:DyaK1cXhvFertLg%3D Occurrence Handle9523592 Occurrence Handle10.1046/j.1471-4159.1998.70041730.x

    Article  CAS  PubMed  Google Scholar 

  • J Saura R Kettler M Da Prada JG Richards (1992) ArticleTitleQuantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain J Neurosci 12 1977–1999 Occurrence Handle1:CAS:528:DyaK38XktVGjtL4%3D Occurrence Handle1578281

    CAS  PubMed  Google Scholar 

  • E Scarr DM Wingerchuk AV Juorio IA Paterson (1994) ArticleTitleThe effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions Neurochem Res 19 153–159 10.1007/BF00966810 Occurrence Handle10.1007/BF00966810 Occurrence Handle1:CAS:528:DyaK2cXpsFKmug%3D%3D Occurrence Handle8183424

    Article  CAS  PubMed  Google Scholar 

  • N Sternic A Kacar S Filipovic M Svetel VS Kostic (1998) ArticleTitleThe therapeutic effect of moclobemide, a reversible selective monoamine oxidase A inhibitor, in Parkinson’s disease Clin Neuropharmacol 21 93–96 Occurrence Handle1:CAS:528:DyaK1cXisVSksr4%3D Occurrence Handle9579294

    CAS  PubMed  Google Scholar 

  • U Ungerstedt (1971) ArticleTitlePostsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system Acta Physiol Scand Suppl 367 69–93

    Google Scholar 

  • SR Wachtel ED Abercrombie (1994) ArticleTitleL-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors J Neurochem 63 108–117 Occurrence Handle1:CAS:528:DyaK2cXksV2qu7g%3D Occurrence Handle8207420 Occurrence Handle10.1046/j.1471-4159.1994.63010108.x

    Article  CAS  PubMed  Google Scholar 

  • KN Westlund TJ Krakower S-W Kwan CW Abell (1993) ArticleTitleIntracellular distribution of monoamine oxidase A in selected regions of rat and monkey brain and spinal cord Brain Res 612 221–230 10.1016/0006-8993(93)91664-E Occurrence Handle10.1016/0006-8993(93)91664-E Occurrence Handle1:CAS:528:DyaK3sXltlKitrg%3D Occurrence Handle8330200

    Article  CAS  PubMed  Google Scholar 

  • MBH Youdim JPM Finberg KF Tipton (1988) Monoamine Oxidase U Trendelenburg N Weiner (Eds) Handbook of experimental pharmacology NumberInSeries90/1 Springer Berlin Heidelberg New York 119–192

    Google Scholar 

  • MBH Youdim A Gross JPM Finberg (2001) ArticleTitleRasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B Br J Pharmacol 132 500–506 10.1038/sj.bjp.0703826 Occurrence Handle10.1038/sj.bjp.0703826 Occurrence Handle1:CAS:528:DC%2BD3MXht1Sgu7o%3D Occurrence Handle11159700

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Finberg, J., Sader-Mazbar, O. Modification of L-DOPA pharmacological activity by MAO inhibitors. J Neural Transm 114, 801–805 (2007). https://doi.org/10.1007/s00702-007-0691-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-007-0691-y

Navigation